Preferred Label : Cyclophosphamide/Prednisone/Rituximab Regimen;
NCIt synonyms : CP-R Regimen; Cyclophosphamide/Prednisone/Rituximab; Cyclophosphamide Plus Rituximab Plus Prednisone; Cyclophosphamide-Prednisone-Rituximab; Cyclophosphamide-Prednisone-Rituximab Regimen; Cyclophosphamide/Prednisone Plus Rituximab; Cyclophosphamide/Prednisone/Rituxan;
NCIt related terms : R-CP (rituximab-blit); R-CP (rituximab-arrx); R-CP (rituximab-rixi); R-CP (rituximab-abbs); R-CP (rituximab-rite); R-CP; R-CP (rituximab-rixa); R-CP (rituximab-pvvr);
NCIt definition : A regimen consisting of cyclophosphamide, prednisone and rituximab that may be used
in the treatment of Castleman disease and Waldenstrom macroglobulinemia/lymphoplasmacytic
lymphoma.;
NCI Metathesaurus CUI : CL1920442;
Codes from synonyms : 33650; 128631; 128317; 127846; 128474; 128788; 128003; 128160;
Origin ID : C201531;
UMLS CUI : C5849066;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
